Skip to main content

You must have JavaScript enabled in order to access this part of the site. Please enable JavaScript and then reload this page in order to continue.

VDP Delays Addition of Continuous Glucose Monitors to Formulary

Last updated on

This is an update to the article titled “VDP to Add Continuous Glucose Monitors to Formulary June 3, 2026.” The Texas Health and Human Services Commission (HHSC) Vendor Drug Program (VDP) is delaying the addition of continuous glucose monitors to the formulary until further notice. The delay will give VDP more time to develop implementation details. VDP will announce a new implementation date with more details in the future.

Email vdp-policy@hhs.texas.gov with comments or questions.